Skip to main content
Clinical Trials/NCT01374737
NCT01374737UnknownPhase 4

ED50 of Dexmedetomidine for Reduction of Emergence Agitation Incidence Undergoing Tonsillectomy or Adenoidectomy in Desflurane Anesthesia Following Sevoflurane Induction in Children

Seoul National University Hospital1 site in 1 country25 target enrollmentStarted: June 2011Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Enrollment
25
Locations
1
Primary Endpoint
agitation

Study Overview

Brief Summary

There are several recommended doses of dexmedetomidine for prevention of emergence agitation in children. In this study, the investigators examine ED50 in prevention of emergence agitation after tonsillectomy or adenoidectomy in children.

Detailed Description

To investigate ED50, Dixon's up and down method will be used.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Single Group
Primary Purpose
Prevention
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
2 Years to 12 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • tonsillectomy or adenoidectomy

Exclusion Criteria

  • recent URI

Arms & Interventions

dexmedetomidine, children

Other

Intervention: Dexmedetomidine (Drug)

Outcomes

Primary Outcomes

agitation

Time Frame: 30 minutes

Secondary Outcomes

  • pain(30 minutes)

Investigators

Sponsor Class
Other

Study Sites (1)

Loading locations...

Similar Trials